Imunon Inc (IMNN)
1.37
-0.03
(-2.14%)
USD |
NASDAQ |
May 20, 16:00
1.36
-0.01
(-0.73%)
Pre-Market: 09:12
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 12.88M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | 1.48% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | 25.56 |
Price to Book Value | 1.515 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | -- |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 99.38% |
Profile
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body’s immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body’s natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. |
URL | https://www.imunon.com |
Investor Relations URL | https://investors.imunon.com/ |
HQ State/Province | New Jersey |
Sector | Health Care |
Industry | Biotechnology |
Equity Style | Small Cap/Value |
Next Earnings Release | Aug. 09, 2024 (est.) |
Last Earnings Release | May. 13, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body’s immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body’s natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. |
URL | https://www.imunon.com |
Investor Relations URL | https://investors.imunon.com/ |
HQ State/Province | New Jersey |
Sector | Health Care |
Industry | Biotechnology |
Equity Style | Small Cap/Value |
Next Earnings Release | Aug. 09, 2024 (est.) |
Last Earnings Release | May. 13, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |